{"id":"W3106551357","doi":"10.1093/europace/euaa199","title":"Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial","year":2020,"lang":"en","type":"article","venue":"EP Europace","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Bayer Vital; St. Jude Medical; Pfizer; Bracco Imaging; Daiichi Sankyo Europe; Sanofi; European Commission; Deutsche Gesellschaft für Neurologie; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; Servier; Biosense Webster; National Institutes of Health; Boston Scientific Corporation","keywords":"Medicine; Edoxaban; Atrial fibrillation; Activated clotting time; Vitamin K antagonist; Catheter ablation; Internal medicine; Cardiology; Ablation; Anesthesia; Warfarin; Heparin; Dabigatran","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001772015,0.000803894,0.002313873,0.0001482535,0.0001736638,0.00096966,0.000541457,0.0006799019,0.002414864],"category_scores_gemma":[0.001550292,0.0002790513,0.001659146,0.0001724235,0.0003890241,0.0004341312,0.000355092,0.001539448,0.000239872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003626338,"about_ca_system_score_gemma":0.0006226449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004984466,"about_ca_topic_score_gemma":0.001452825,"domain_scores_codex":[0.9993446,0.0003900755,0.00003758415,0.00009609593,0.0000396378,0.00009202161],"domain_scores_gemma":[0.9990692,0.0004147154,0.0001867114,0.00007601704,0.00004096364,0.0002123878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9811105,0.001300738,0.002546399,0.0003282986,0.001688191,0.00005140755,0.00002850868,0.0003935633,0.001038405,0.0001479186,0.0004536121,0.01091259],"study_design_scores_gemma":[0.898827,0.07621003,0.01587207,0.00009596766,0.00466148,0.000174213,0.00005850027,0.001550959,0.0008360356,0.000520393,0.001169553,0.00002368688],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993847,0.003581081,0.0002963495,0.0003736782,0.0002010714,0.0002276939,0.0003655935,0.00002468803,0.001082915],"genre_scores_gemma":[0.9951767,0.001457745,0.0005333887,0.0005117898,0.0002836562,0.0002772963,0.0006360883,0.000009013391,0.001114377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002414864,"threshold_uncertainty_score":0.009371459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07810344085779422,"score_gpt":0.3446748609192762,"score_spread":0.2665714200614819,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}